Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. (IRWD) Stock Overview

Explore Ironwood Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IRWD●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.87
$0.06(1.25%)
U.S. Market opens in 12h 59m

Ironwood Pharmaceuticals, Inc. (IRWD)

Meyka AI Score

Z

Key Financials

Market Cap806.2M
P/E Ratio5.35
EPS (TTM)$0.78
ROE-0.93%
Fundamental Analysis

AI Price Forecasts

1 Month$5.27
3 Months$6.24
1 Year Target$6.57

IRWD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ironwood Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IRWD on the NASDAQ shows an RSI of 76.97, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $6.57 for the NASDAQ listing.

Key metrics behind Ironwood Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of 5.35 and a market capitalization of 806.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of IRWD on the NASDAQ.

Price Performance (NASDAQ: IRWD)

1-Day Change
1.25%
5-Day Change
14.32%
1-Month Change
27.49%
3-Month Change
13.26%
6-Month Change
16.79%
Year-to-Date (YTD) Change
44.51%
1-Year Change
68.51%
3-Year Change
-48.14%
5-Year Change
-60.37%
All-Time (Max) Change
-58.20%

Contact Information

https://www.ironwoodpharma.com
617 621 7722
100 Summer Street, Boston, MA, 02110

Company Facts

1,000 Employees
IPO DateFeb 3, 2010
CountryUS
Actively Trading

Frequently Asked Questions